LINC00426 and hepatocellular carcinoma: LINC00426 is known to be associated with lung adenocarcinoma (LUAD) progression (Li H. et al., 2020), doxorubicin resistance in osteosarcoma (OSA) (Wang L. et al., 2020), immune-cell infiltration in clear cell renal cell carcinoma (ccRCC) (Xiang et al., 2021) and prognosis in hepatocellular carcinoma (HCC) patients (Zhu et al., 2020).